The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study.
about
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignanciesIgM multiple myeloma: report of four cases and review of the literature.Liposomal chemotherapeutics.High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan.
P2860
The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The evaluation of gemcitabine ...... outhwest Oncology Group study.
@ast
The evaluation of gemcitabine ...... outhwest Oncology Group study.
@en
type
label
The evaluation of gemcitabine ...... outhwest Oncology Group study.
@ast
The evaluation of gemcitabine ...... outhwest Oncology Group study.
@en
prefLabel
The evaluation of gemcitabine ...... outhwest Oncology Group study.
@ast
The evaluation of gemcitabine ...... outhwest Oncology Group study.
@en
P2093
P356
P1476
The evaluation of gemcitabine ...... outhwest Oncology Group study.
@en
P2093
Dennis F Moore
James K Weick
John J Crowley
Mohamed A Hussein
P2888
P304
P356
10.1023/A:1014493007347
P577
2002-02-01T00:00:00Z
P6179
1004827670